CHARLOTTE, N.C. (PRWEB)
February 04, 2020

cbdMD, Inc. a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), and the Registrar at National Day Calendar, celebrate the second annual “National Hemp Day.”

cbdMD founded the holiday on Feb. 4, 2019, to increase overall awareness and coverage of the entire hemp industry. Due to the passing of the 2018 Farm Bill, hemp-based products – such as CBD oil, plastics, paint, insulation, and biofuels – are more readily available for consumer use than ever before. Thanks to the recent support surrounding the industry, several studies project that the hemp and CBD markets could become a multibillion-dollar industry in just a few short years.

“Celebrating another holiday we founded here at cbdMD is a tremendous honor,” said Ken Cohn, Chief Marketing Officer at cbdMD. “We’re hoping that people will continue to educate themselves on the hemp industry, while continuing to explore the many CBD applications and how they can support an overall outlook on daily well-being.”

National Hemp Day, in conjunction with National CBD Day (August 8), National CBD Month (January), and National Hemp Month (July), was initiated to create awareness while highlighting the many applications of hemp-derived CBD and how it can support millions of people across the world every year. Visit http://www.cbdMD.com to learn more.

About cbdMD

cbdMD, Inc. is a nationally recognized consumer cannabidiol (CBD) brand whose current products include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet products. cbdMD is also a proud partner of Bellator MMA, Life Time, Inc., and Supercross, and has one of the largest rosters of professional sports athletes who are part of “Team cbdMD.” To learn more about cbdMD and our comprehensive line of over 100 SKUs of U.S. produced, THC-free* CBD products, please visit http://www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 4,000 retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as ”should,” ”may,” ”intends,” ”anticipates,” ”believes,” ”estimates,” ”projects,” ”forecasts,” ”expects,” ”plans,” and ”proposes.” These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, including, but not limited to, our ability to expand the sales of our CBD products through our partnerships, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the Securities and Exchange Commission (the “SEC”) on December 18, 2019 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

*THC-free means undetectable at the lowest level which can be consistently detected using valid scientific analytical tools.

Share article on social media or email: